FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use

Retrieved on: 2025-01-28 20:07:53

Tags for this article:

Kidney diseases

Semaglutide

Chronic kidney disease

Kidney disease

Kidney transplantation

Kidney failure

Novo Nordisk

Kidney dialysis

Assessment of kidney function

Diabetes

Anti-obesity medication

Canagliflozin

United States

Click the tags to see associated articles and topics

FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use. View article details on hiswai:

Excerpt

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.

Article found on: www.cnbc.com

View Original Article